• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SPECTRANETICS STELLAREX 0.014 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SPECTRANETICS STELLAREX 0.014 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER Back to Search Results
Model Number AA14SX025150150
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Death (1802)
Event Date 03/21/2019
Event Type  Death  
Manufacturer Narrative
The patient's ethnicity and race are unknown.This information was not available from the facility.The patient's cause of death was unrelated to the study device or procedure.This is being reported as a follow-up to the clinical study.Udi and pma numbers are not applicable.This device was used in clinical application prior to being available in the us.(b)(6).During the index procedure, the product worked as intended and the device was discarded, thus no product evaluation was required.Although the cause of death is unrelated to the study device, death is listed in the ifu as a potential complications/ adverse events.
 
Event Description
It was reported through a clinical study that during the index procedure on (b)(6) 2019, a stellarex catheter was used to treat the target lesion of the left proximal and distal anterior tibial artery.Approximately 20 months post index procedure, the patient expired due to respiratory insufficiency caused by covid 19 virus and heart failure on (b)(6) 2020.The physician indicated this is not related to the study device or procedure.
 
Manufacturer Narrative
Block g3: corrected study name from illuminate btk pm to btk pm.Block g5: pma number is not applicable.The device is a commercial product with a ce mark that was used as part of a clinical study.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STELLAREX 0.014 OTW DRUG-COATED ANGIOPLASTY BALLOON
Type of Device
DCB PTA CATHETER
Manufacturer (Section D)
SPECTRANETICS
6531 dumbarton circle
fremont CA 94555
MDR Report Key11051899
MDR Text Key223050394
Report Number3009784280-2020-00317
Device Sequence Number1
Product Code ONU
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,study
Type of Report Initial,Followup
Report Date 12/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/29/2020
Device Model NumberAA14SX025150150
Device Catalogue NumberAA14SX025150150
Device Lot NumberF8E18L08A
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/21/2020
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/20/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age71 YR
Patient Weight48
-
-